Quercis Pharma Secures USD 150 Million Investment Commitment from GEM as Company Seeks to Go Public
/PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announced that it...